BREA, Calif., Jan. 28, 2025 /PRNewswire/ -- Beckman Coulter Diagnostics, a global leader in clinical diagnostics, today announced the U.S. Food and Drug Administration (FDA) has granted ...

Washington D.C., Jan. 23, 2025 (GLOBE NEWSWIRE) -- The Global Alzheimer’s Platform Foundation® (GAP) is pleased to welcome Beckman Coulter Diagnostics as a strategic partner in the Bio-Hermes ...

BREA, Calif., Jan. 28, 2025 /PRNewswire/ -- Beckman Coulter Diagnostics, a global leader in clinical diagnostics, today announced the U.S. Food and Drug Administration (FDA) has granted Breakthrough ...

15, 2025 /PRNewswire/ -- Beckman ... all stages of AD and in research has shown to distinguish AD from other neurodegenerative disorders. Leveraging the ALZpath p-Tau217 antibody, the new Beckman ...

BREA, Calif., Jan. 15, 2025 /PRNewswire/ -- Beckman Coulter Diagnostics, a global leader in advanced diagnostics, today announced availability of new Research Use Only (RUO) blood-based biomarker ...

15, 2025 /PRNewswire/ -- Beckman Coulter Diagnostics ... that plasma p-Tau217 is a sensitive biomarker present through all stages of AD and in research has shown to distinguish AD from other ...